This inventor holds 2 USPTO granted patents. Top assignees: Dongkook Pharmaceutical Co., Ltd., Other. Active years: 1995-1996.
Company Filing History:
2 out of 25 
2 out of 834,411 Years Active: 1995-1996
Title: L A Saburoba: Innovator in Aclacinomycin Production
Introduction
L A Saburoba is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of biotechnology, particularly in the production of aclacinomycins, which are important compounds in cancer treatment. With a total of 2 patents, his work has garnered attention in the scientific community.
Latest Patents
L A Saburoba's latest patents include a method for producing aclacinomycins A, B, Y using a novel strain of Streptomyces. This method involves cultivating Streptomyces lavendofoliae DKRS (KCTC 0092BP), which is capable of producing aclacinomycins A, B, Y, and their aglycone with higher yields. The process allows for selective production of aclacinomycin A or Y by adjusting the pH of the cultured broth to 4.4 or 4.6 using acetate buffer or hydrochloric acid, respectively.
Career Highlights
Throughout his career, L A Saburoba has worked with Dongkook Pharmaceutical Co., Ltd., where he has applied his expertise in biotechnology. His innovative approaches have contributed to advancements in the production of anti-tumor aclacinomycins.
Collaborations
L A Saburoba has collaborated with notable colleagues, including Myung K Kim and Hak Ryol Kim. Their combined efforts have furthered research in the field of aclacinomycin production.
Conclusion
L A Saburoba's contributions to the field of biotechnology, particularly in aclacinomycin production, highlight his role as an influential inventor. His innovative methods and collaborations continue to impact cancer treatment research.